Bifidobacterium animalis subsp. lactis 420 mitigates the pathological impact of myocardial infarction in the mouse

Beneficial Microbes

Volumn 8, Issue 2, 2017, Pages 257-269

  Danilo, C A ^a   Constantopoulos, E ^a   McKee, L A ^a,c   Chen, H ^a,d   Regan, J A ^a   Lipovka, Y ^a   Lahtinen, S ^b   Stenman, L K ^b   Nguyen, T V V ^a,c,d   Doyle, K P ^a,c,d   Slepian, M J ^a   Khalpey, Z I ^c   Konhilas, J P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b DUPONT COMPANY   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

B. animalis ssp. lactis; Cardiovascular disease; Inflammation; Probiotics; Regulatory T cells

Indexed keywords

BASILIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROBIOTIC AGENT; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENT; CARDIOTONIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM ANIMALIS SUBSP LACTIS 420; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; EPIGENETICS; GENETIC TRANSCRIPTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; MALE; MOUSE; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; PROTEIN PROCESSING; REGULATORY T LYMPHOCYTE; TREATMENT OUTCOME; WILD TYPE MOUSE; ANIMAL; C57BL MOUSE; DIETARY SUPPLEMENT; IMMUNOLOGY; INFLAMMATION; LACTOBACILLUS SALIVARIUS; MICROBIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIFIDOBACTERIUM ANIMALIS; CARDIOTONIC AGENTS; DIETARY SUPPLEMENTS; INFLAMMATION; LACTOBACILLUS SALIVARIUS; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; PROBIOTICS; T-LYMPHOCYTES, REGULATORY;

EID: 85018262974     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2016.0119     Document Type: Article

References (51)

1. Amar, J., Chabo, C., Waget, A., Klopp, P., Vachoux, C., Bermudez-Humaran, L.G., Smirnova, N., Berge, M., Sulpice, T., Lahtinen, S., Ouwehand, A., Langella, P., Rautonen, N., Sansonetti, P.J. and Burcelin, R., 2011. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Molecular Medicine 3: 559-572
2. Arpaia, N., Campbell, C., Fan, X., Dikiy, S., Van der Veeken, J., DeRoos, P., Liu, H., Cross, J.R., Pfeffer, K., Coffer, P.J. and Rudensky, A.Y., 2013. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504: 451-455
3. Brandtzaeg, P., 2009. Mucosal immunity: induction, dissemination, and effector functions. Scandinavian Journal of Immunology 70: 505-515
4. Bujak, M., Dobaczewski, M., Gonzalez-Quesada, C., Xia, Y., Leucker, T., Zymek, P., Veeranna, V., Tager, A.M., Luster, A.D. and Frangogiannis, N.G., 2009. Induction of the CXC chemokine interferon-gammainducible protein 10 regulates the reparative response following myocardial infarction. Circulation Research 105: 973-983
5. Cani, P., Neyrinck, A., Fava, F., Knauf, C., Burcelin, R., Tuohy, K., Gibson, G. and Delzenne, N., 2007a. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50: 2374-2383
6. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., Waget, A., Delmee, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrieres, J., Tanti, J.F., Gibson, G.R., Casteilla, L., Delzenne, N.M., Alessi, M.C. and Burcelin, R., 2007b. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772
7. Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M. and Burcelin, R., 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat dietinduced obesity and diabetes in mice. Diabetes 57: 1470-1481
8. Chen, H. and Konhilas, J.P., 2013. Probiotic species on cardiovascular disease: the use of probiotics to reduce cardiovascular disease risk factors. In: Watson, R.R. and Preedy, V.R. (eds.) Bioactive food as dietary interventions for cardiovascular disease. Elsevier, Boston, MA, USA, pp. 303-317
9. Collado, M.C., Meriluoto, J. and Salminen, S., 2007. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Letters in Applied Microbiology 45: 454-460
10. Daniel, C., Poiret, S., Goudercourt, D., Dennin, V., Leyer, G. and Pot, B., 2006. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Applied and Environmental Microbiology 72: 5799-5805
11. De la Serre, C.B., Ellis, C.L., Lee, J., Hartman, A.L., Rutledge, J.C. and Raybould, H.E., 2010. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. American Journal of Physiology-Gastrointestinal and Liver Physiology 299: G440-G448
12. Ebel, B., Lemetais, G., Beney, L., Cachon, R., Sokol, H., Langella, P. and Gervais, P., 2014. Impact of probiotics on risk factors for cardiovascular diseases: a review. Critical Reviews in Food Science and Nutrition 54: 175-189
13. Fang, J. and Alderman, M.H., 2006. Impact of the increasing burden of diabetes on acute myocardial infarction in New York City: 1990-2000. Diabetes 55: 768-773
14. Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2001. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Available at: http://tinyurl.com/8bccc3r
15. Fedorak, R.N., 2008. Understanding why probiotic therapies can be effective in treating IBD. Journal of Clinical Gastroenterology 42 Suppl. 3: S111-115
16. Frangogiannis, N.G., 2012. Regulation of the inflammatory response in cardiac repair. Circular Research 110: 159-173
17. Frangogiannis, N.G., Smith, C.W. and Entman, M.L., 2002. The inflammatory response in myocardial infarction. Cardiovascular Research 53: 31-47
18. Gan, X.T., Ettinger, G., Huang, C.X., Burton, J.P., Haist, J.V., Rajapurohitam, V., Sidaway, J.E., Martin, G., Gloor, G.B., Swann, J.R., Reid, G. and Karmazyn, M., 2014. Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circulation: Heart Failure 7: 491-499
19. Garidou, L., Pomie, C., Klopp, P., Waget, A., Charpentier, J., Aloulou, M., Giry, A., Serino, M., Stenman, L., Lahtinen, S., Dray, C., Iacovoni, J.S., Courtney, M., Collet, X., Amar, J., Servant, F., Lelouvier, B., Valet, P., Eberl, G., Fazilleau, N., Douin-Echinard, V., Heymes, C. and Burcelin, R., 2015. The gut microbiota regulates intestinal CD4 T cells expressing RORgammat and controls metabolic disease. Cell Metabolism 22: 100-112
20. Gomez-Hurtado, I., Santacruz, A., Peiro, G., Zapater, P., Gutierrez, A., Perez-Mateo, M., Sanz, Y. and Frances, R., 2011. Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis. PLoS ONE 6: e23037
21. Guo, Y., Xiao, P., Lei, S., Deng, F., Xiao, G.G., Liu, Y., Chen, X., Li, L., Wu, S., Chen, Y., Jiang, H., Tan, L., Xie, J., Zhu, X., Liang, S. and Deng, H., 2008. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochimica et Biophysica Sinica 40: 426-436
22. Hakansson, A. and Molin, G., 2011. Gut microbiota and inflammation. Nutrients 3: 637-682
23. Huntington, N.D., 2014. The unconventional expression of IL-15 and its role in NK cell homeostasis. Immunology and Cell Biology 92: 210-213
24. Ikemizu, S., Chirifu, M. and Davis, S.J., 2012. IL-2 and IL-15 signaling complexes: different but the same. Nature Immunology 13: 1141-1142
25. Kaikita, K., Hayasaki, T., Okuma, T., Kuziel, W.A., Ogawa, H. and Takeya, M., 2004. Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. American Journal of Pathology 165: 439-447
26. Klein, A., Friedrich, U., Vogelsang, H. and Jahreis, G., 2008. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. European Journal of Clinical Nutrition 62: 584-593
27. Lam, V., Su, J., Koprowski, S., Hsu, A., Tweddell, J.S., Rafiee, P., Gross, G.J., Salzman, N.H. and Baker, J.E., 2012. Intestinal microbiota determine severity of myocardial infarction in rats. Faseb Journal 26: 1727-1735
28. Lefer, D.J. and Bolli, R., 2011. Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation. Journal of Cardiovascular Pharmacology and Therapeutics 16: 332-339
29. Lorchner, H., Poling, J., Gajawada, P., Hou, Y., Polyakova, V., Kostin, S., Adrian-Segarra, J.M., Boettger, T., Wietelmann, A., Warnecke, H., Richter, M., Kubin, T. and Braun, T., 2015. Myocardial healing requires Reg3beta-dependent accumulation of macrophages in the ischemic heart. Nature Medicine 21: 353-362
30. Lukjancenko, O., Ussery, D.W. and Wassenaar, T.M., 2012. Comparative genomics of Bifidobacterium, Lactobacillus and related probiotic genera. Microbial Ecology 63: 651-673
31. Marchant, D.J., Boyd, J.H., Lin, D.C., Granville, D.J., Garmaroudi, F.S. and McManus, B.M., 2012. Inflammation in myocardial diseases. Circular Research 110: 126-144
32. Mengheri, E., 2008. Health, probiotics, and inflammation. Journal of Clinical Gastroenterology 42 Suppl. 3: S177-178
33. Nahrendorf, M., Swirski, F.K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.L., Libby, P., Weissleder, R. and Pittet, M.J., 2007. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. Journal of Experimental Medicine 204: 3037-3047
34. Nian, M., Lee, P., Khaper, N. and Liu, P., 2004. Inflammatory cytokines and postmyocardial infarction remodeling. Circular Research 94: 1543-1553
35. Ohkura, N., Kitagawa, Y. and Sakaguchi, S., 2013. Development and maintenance of regulatory T cells. Immunity 38: 414-423
36. Okamoto, N., Noma, T., Ishihara, Y., Miyauchi, Y., Takabatake, W., Oomizu, S., Yamaoka, G., Ishizawa, M., Namba, T., Murakami, K., Iwado, Y., Ohmori, K. and Kohno, M., 2014. Prognostic value of circulating regulatory T cells for worsening heart failure in heart failure patients with reduced ejection fraction. International Heart Journal 55: 271-277
37. Pere, H., Tanchot, C., Bayry, J., Terme, M., Taieb, J., Badoual, C., Adotevi, O., Merillon, N., Marcheteau, E., Quillien, V.R., Banissi, C., Carpentier, A., Sandoval, F., Nizard, M., Quintin-Colonna, F., Kroemer, G., Fridman, W.H., Zitvogel, L., Oudard, S.P. and Tartour, E., 2012. Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer. Oncoimmunology 1: 326-333
38. Roessler, A., Forssten, S.D., Glei, M., Ouwehand, A.C. and Jahreis, G., 2012. The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study. Clinical Nutrition 31: 22-29. Sakaguchi, S., Miyara, M., Costantino, C.M. and Hafler, D.A., 2010. FOXP3+ regulatory T cells in the human immune system. Nature Reviews Immunology 10: 490-500
39. Sakaguchi, S., Miyara, M., Costantino, C.M. and Hafler, D.A., 2010. FOXP3+ regulatory T cells in the human immune system. Nature Reviews Immunology 10: 490-500
40. Setiady, Y.Y., Coccia, J.A. and Park, P.U., 2010. In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes. European Journal of Immunology 40: 780-786
41. Slepian, M. and Gottehrer, N.R., 2009. Oral-body inflammatory connection. Dent Today 28: 138, 140, 142-133
42. Smelt, M.J., De Haan, B.J., Bron, P.A., Van Swam, I., Meijerink, M., Wells, J.M., Faas, M.M. and De Vos, P., 2013. Probiotics can generate FoxP3 T-cell responses in the small intestine and simultaneously inducing CD4 and CD8 T cell activation in the large intestine. PLoS ONE 8: e68952
43. Stenman, L.K., Waget, A., Garret, C., Klopp, P., Burcelin, R. and Lahtinen, S., 2014. Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in dietinduced obese mice. Beneficial Microbes 5: 437-445
44. Takagawa, J., Zhang, Y., Wong, M.L., Sievers, R.E., Kapasi, N.K., Wang, Y., Yeghiazarians, Y., Lee, R.J., Grossman, W. and Springer, M.L., 2007. Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area-and length-based approaches. Journal of Applied Physiology 102: 2104-2111
45. Tang, T.T., Yuan, J., Zhu, Z.F., Zhang, W.C., Xiao, H., Xia, N., Yan, X.X., Nie, S.F., Liu, J., Zhou, S.F., Li, J.J., Yao, R., Liao, M.Y., Tu, X., Liao, Y.H. and Cheng, X., 2012. Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Research in Cardiology 107: 232
46. Toral, M., Gomez-Guzman, M., Jimenez, R., Romero, M., Sanchez, M., Utrilla, M.P., Garrido-Mesa, N., Rodriguez-Cabezas, M.E., Olivares, M., Galvez, J. and Duarte, J., 2014. The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. Clinical Science 127: 33-45
47. Ventura, M., O'Flaherty, S., Claesson, M.J., Turroni, F., Klaenhammer, T.R., Van Sinderen, D. and O'Toole, P.W., 2009. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nature Reviews Microbiology 7: 61-71
48. Wang, L., De Zoeten, E.F., Greene, M.I. and Hancock, W.W., 2009. Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells. Nature Reviews Drug Discovery 8: 969-981
49. Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., Dugar, B., Feldstein, A.E., Britt, E.B., Fu, X., Chung, Y.M., Wu, Y., Schauer, P., Smith, J.D., Allayee, H., Tang, W.H., DiDonato, J.A., Lusis, A.J. and Hazen, S.L., 2011. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472: 57-63
50. Weirather, J., Hofmann, U.D., Beyersdorf, N., Ramos, G.C., Vogel, B., Frey, A., Ertl, G., Kerkau, T. and Frantz, S., 2014. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circular Research 115: 55-67
51. Zuidema, M.Y. and Zhang, C., 2010. Ischemia/reperfusion injury: the role of immune cells. World Journal of Cardiology 2: 325-332